Antibiotic regimens tailored by clinical pharmacist supported by intensivist enhance rational use of antibiotics | ||||
| Egyptian Journal of Anaesthesia | ||||
| Volume 40, Issue 1, December 2024, Page 292-299 PDF (1.72 MB) | ||||
| DOI: TEJA-2022-0245 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Islam M. El-Bardan; Ibrahim M. Mabrouk; Bassem N. Beshay; Heba O. Shaker; Ahmed S. Shehab | ||||
| Abstract | ||||
| Background High antibiotics utility rates have been observed in surgical intensive care units (SICU). The present study was performed to evaluate the effect of engaging a clinical pharmacist in SICU on rational use of antibiotic treatment. Methods This retrospective quasi-experimental experiment involved 505 patients, over a period of one year, admitted to emergency department surgical/trauma ICU of a large tertiary care hospital. Before and during pharmacist participation periods of six months, 226 and 153 patients, respectively, are compared. Results Antibiotics consumption pattern changed with a decrease in total antibiotic consumption from 101.42 to 94.1 Defined Daily Dose/100 patients’ days after the clinical pharmacist participation, in addition to, a statistically significant rise ( = 0.001) in percentage of appropriateness of the prescribed antibiotic therapy from 72.1% to 86.3%. Time to control infection (days) was not statistically different ( = 0.825) in both periods. The average ICU days of stay was statistically significant longer ( = 0.046) during pharmacist attendance (4.42 ± 5.61) in comparison with period without pharmacist attendance (3.31 ± 3.66). The difference in ICU mortality rate was not statistically significance ( = 0.217). Cost per stay increased by 65% during pharmacist intervention period. Conclusions Antibiotic management with pharmacist participation as a part of multidisciplinary team with intensivist can promote rate of the appropriateness of the prescribed antibiotic therapy, lower utility of antibiotic consumption, but with a longer ICU stay, no mortality reduction, and higher expenses per stay. Trial Registry ClinicalTrials.gov: NCT04931914. | ||||
| Keywords | ||||
| Intensive Care Unit; antibiotics; Clinical pharmacist; emergency department | ||||
|
Statistics Article View: 63 PDF Download: 65 |
||||
